Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ryosuke Saigusa

Showing results (11-20 of 55) with videos related to

Pageof 6
Sort By:
The Journal of Investigative Dermatology|December 4, 2018
Cyclophosphamide Pulse Therapy Normalizes Vascular Abnormalities in a Mouse Model of Systemic Sclerosis VasculopathyTakashi Yamashita, Yoshihide Asano, Ryosuke Saigusa, et al.
Journal of Dermatological Science|January 22, 2020
Regulation of skin fibrosis by RALDH1-producing dermal dendritic cells via retinoic acid-mediated regulatory T cell induction: A role in sclerodermaShunsuke Miura, Yoshihide Asano, Ryosuke Saigusa, et al.
Arthritis Research & Therapy|May 9, 2021
Fli1 deficiency suppresses RALDH1 activity of dermal dendritic cells and related induction of regulatory T cells: a possible role in sclerodermaShunsuke Miura, Yusuke Watanabe, Ryosuke Saigusa, et al.
Rheumatology (Oxford, England)|November 30, 2019
Fli1 deficiency induces endothelial adipsin expression, contributing to the onset of pulmonary arterial hypertension in systemic sclerosisTakuya Miyagawa, Takashi Taniguchi, Ryosuke Saigusa, et al.
Experimental Dermatology|December 15, 2015
A potential contribution of altered cathepsin L expression to the development of dermal fibrosis and vasculopathy in systemic sclerosisTakashi Yamashita, Yoshihide Asano, Takashi Taniguchi, et al.
The Journal of Dermatology|May 1, 2016
Linear scleroderma with prominent multiple lymphadenopathy followed by the development of polymyositis: A case report and review of published workTakehiro Takahashi, Yoshihide Asano, Maiko Hirakawa, et al.
Experimental Dermatology|June 28, 2018
CXCL13 produced by macrophages due to Fli1 deficiency may contribute to the development of tissue fibrosis, vasculopathy and immune activation in systemic sclerosisTakashi Taniguchi, Takuya Miyagawa, Satoshi Toyama, et al.
The Journal of Dermatology|June 10, 2020
Decreased serum cathepsin S levels in patients with systemic sclerosis-associated interstitial lung diseaseSatoshi Toyama, Takashi Yamashita, Ryosuke Saigusa, et al.
Experimental Dermatology|November 26, 2014
A possible contribution of endothelial CCN1 downregulation due to Fli1 deficiency to the development of digital ulcers in systemic sclerosisRyosuke Saigusa, Yoshihide Asano, Takashi Taniguchi, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 25, 2015
Multifaceted contribution of the TLR4-activated IRF5 transcription factor in systemic sclerosisRyosuke Saigusa, Yoshihide Asano, Takashi Taniguchi, et al.
Pageof 6

Showing results (11-20 of 55) with videos related to

Sort By:
Pageof 6
The Journal of Investigative Dermatology|December 4, 2018
Cyclophosphamide Pulse Therapy Normalizes Vascular Abnormalities in a Mouse Model of Systemic Sclerosis VasculopathyTakashi Yamashita, Yoshihide Asano, Ryosuke Saigusa, et al.
Journal of Dermatological Science|January 22, 2020
Regulation of skin fibrosis by RALDH1-producing dermal dendritic cells via retinoic acid-mediated regulatory T cell induction: A role in sclerodermaShunsuke Miura, Yoshihide Asano, Ryosuke Saigusa, et al.
Arthritis Research & Therapy|May 9, 2021
Fli1 deficiency suppresses RALDH1 activity of dermal dendritic cells and related induction of regulatory T cells: a possible role in sclerodermaShunsuke Miura, Yusuke Watanabe, Ryosuke Saigusa, et al.
Rheumatology (Oxford, England)|November 30, 2019
Fli1 deficiency induces endothelial adipsin expression, contributing to the onset of pulmonary arterial hypertension in systemic sclerosisTakuya Miyagawa, Takashi Taniguchi, Ryosuke Saigusa, et al.
Experimental Dermatology|December 15, 2015
A potential contribution of altered cathepsin L expression to the development of dermal fibrosis and vasculopathy in systemic sclerosisTakashi Yamashita, Yoshihide Asano, Takashi Taniguchi, et al.
The Journal of Dermatology|May 1, 2016
Linear scleroderma with prominent multiple lymphadenopathy followed by the development of polymyositis: A case report and review of published workTakehiro Takahashi, Yoshihide Asano, Maiko Hirakawa, et al.
Experimental Dermatology|June 28, 2018
CXCL13 produced by macrophages due to Fli1 deficiency may contribute to the development of tissue fibrosis, vasculopathy and immune activation in systemic sclerosisTakashi Taniguchi, Takuya Miyagawa, Satoshi Toyama, et al.
The Journal of Dermatology|June 10, 2020
Decreased serum cathepsin S levels in patients with systemic sclerosis-associated interstitial lung diseaseSatoshi Toyama, Takashi Yamashita, Ryosuke Saigusa, et al.
Experimental Dermatology|November 26, 2014
A possible contribution of endothelial CCN1 downregulation due to Fli1 deficiency to the development of digital ulcers in systemic sclerosisRyosuke Saigusa, Yoshihide Asano, Takashi Taniguchi, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 25, 2015
Multifaceted contribution of the TLR4-activated IRF5 transcription factor in systemic sclerosisRyosuke Saigusa, Yoshihide Asano, Takashi Taniguchi, et al.
Pageof 6